United States. Securities and Exchange Commission
Comera Life Sciences Holdings, Inc. Files FORM 8-K with SEC: Disclosure of Regulation FD
Comera Life Sciences Holdings, Inc., a Delaware-based biotech company, has filed a current report (FORM 8-K) with the U.S. Securities and Exchange Commission (SEC) on October 2, 2023. The report provides details on the company's recent activities, including a private placement of common stock and warrants, and